TRimetazidine for acUte on Chronic Liver Failure STudy

PHASE1SuspendedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 28, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Acute-On-Chronic Liver Failure
Interventions
DRUG

Trimetazidine

Subjects with receive up to 60 mg daily

Trial Locations (24)

Unknown

Medical University of Graz, Graz

Medical University of Innsbruck, Innsbruck

Medical University of Vienna, Vienna

University of Antwerp, Antwerp

Erasme Hospital, Brussels

Hospital Claude Huriez, Lille

Hospital Pitie-Salpetriere, Paris

Rennes University Hospital, Rennes

Hôpital Paul Brousse, Villejuif

University of Essen, Essen

JW Goethe Clinic, Frankfurt

Universitätsklinikum Halle Klinik und Poliklinik für Innere Medizin I, Halle

University of Hannover, Hanover

University of Heidelberg, Heidelberg

University of Leipzig, Leipzig

University of Münster, Münster

Hospital Clinic, Barcelona

Hospital Valle de Hebron, Barcelona

Hospital Reina Sofia, Córdoba

Hospital Gregorio Marañón, Madrid

Hospital Puerta de Hierro, Madrid

Hospital Ramon y Cajal, Madrid

Hospital Marques de Valdecilla Santander, Santander

Hospital Virgen del Rocio, Seville

Sponsors
All Listed Sponsors
lead

Martin Pharmaceuticals

INDUSTRY

NCT03737448 - TRimetazidine for acUte on Chronic Liver Failure STudy | Biotech Hunter | Biotech Hunter